Morgan Stanley’s LifePoint Health, Inc. LPNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-286,887
Closed -$18.5M 7000
2018
Q3
$18.5M Buy
286,887
+165,366
+136% +$10.1M ﹤0.01% 1770
2018
Q2
$5.93M Buy
121,521
+37,654
+45% +$1.95M ﹤0.01% 2955
2018
Q1
$3.94M Buy
83,867
+9,519
+13% +$458K ﹤0.01% 3298
2017
Q4
$3.7M Sell
74,348
-210,095
-74% -$10.4M ﹤0.01% 3421
2017
Q3
$16.5M Buy
284,443
+224,861
+377% +$13.4M ﹤0.01% 1751
2017
Q2
$4M Sell
59,582
-38,426
-39% -$2.43M ﹤0.01% 3098
2017
Q1
$6.42M Buy
98,008
+20,338
+26% +$1.26M ﹤0.01% 2606
2016
Q4
$4.41M Buy
77,670
+23,904
+44% +$1.38M ﹤0.01% 3127
2016
Q3
$3.19M Sell
53,766
-56,732
-51% -$3.4M ﹤0.01% 3109
2016
Q2
$7.22M Sell
110,498
-18,846
-15% -$1.28M ﹤0.01% 2258
2016
Q1
$8.96M Buy
129,344
+57,165
+79% +$3.82M ﹤0.01% 1943
2015
Q4
$5.3M Sell
72,179
-54,098
-43% -$3.85M ﹤0.01% 2613
2015
Q3
$8.95M Buy
126,277
+20,302
+19% +$1.65M ﹤0.01% 2069
2015
Q2
$9.21M Sell
105,975
-11,932
-10% -$902K ﹤0.01% 2190
2015
Q1
$8.66M Buy
117,907
+26,794
+29% +$1.9M ﹤0.01% 2215
2014
Q4
$6.55M Sell
91,113
-36,549
-29% -$2.53M ﹤0.01% 2466
2014
Q3
$8.83M Buy
127,662
+103,803
+435% +$7.3M ﹤0.01% 2138
2014
Q2
$1.48M Sell
23,859
-5,020
-17% -$294K ﹤0.01% 3727
2014
Q1
$1.57M Sell
28,879
-18,528
-39% -$990K ﹤0.01% 3628
2013
Q4
$2.5M Sell
47,407
-9,562
-17% -$480K ﹤0.01% 3210
2013
Q3
$2.66M Sell
56,969
-43,625
-43% -$2.09M ﹤0.01% 2995
2013
Q2
$4.91M Buy
+100,594
New +$4.82M ﹤0.01% 2346

Other funds holding LPNT

Morgan Stanley's LPNT Position: Q4 2018 in Review

Morgan Stanley sold out of LifePoint Health, Inc. (LPNT) in Q4 2018, closing a stake of 286,887 shares — an estimated $18.5M sold.

Morgan Stanley first reported a position in LPNT in Q2 2013 and held it in 22 quarters. The position peaked at $18.5M in Q3 2018. 3 funds tracked by Wall St. Rank hold LPNT as of Q4 2018.

  • Morgan Stanley reported no remaining LifePoint Health, Inc. position as of Q4 2018 after selling out during the quarter.
  • Morgan Stanley sold 286,887 LifePoint Health, Inc. shares in Q4 2018, an estimated $18.5M.
  • Morgan Stanley first reported a position in LifePoint Health, Inc. in Q2 2013 and held it in 22 quarters.
  • Morgan Stanley's LifePoint Health, Inc. position peaked at $18.5M in Q3 2018.
  • 3 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q4 2018.

Based on Morgan Stanley's 13F filing for Q4 2018, filed 14 Feb 2019.